FUNCTION AND REGULATION OF VLA MOLECULES ON T CELLS
FUNCTION AND REGULATION OF VLA MOLECULES ON T CELLS
批准号:
3305974
负责人:
MARTIN E HEMLER
金额:
$10.23万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1991
资助国家:
美国
项目状态:
已结题
起止时间:
1991-08-01 至 1995-07-31
关键词:
DNA binding protein T cell receptor T lymphocyte antiantibody binding proteins cell adhesion molecules clone cells complementary DNA cytoskeletal proteins extracellular matrix proteins gene expression integrins laboratory mouse leukocyte activation /transformation ligands monoclonal antibody mutant protein biosynthesis protein signal sequence protein structure function surface antigens
中文摘要
T细胞在发育过程中和成熟后,
VLA蛋白家族中的受体与其他细胞相互作用,
细胞外基质从初步结果来看,VLA
蛋白质不仅是底物或靶结构的受体
参与细胞定位和迁移,而且还可以直接
有助于通过T细胞发出信号,并且可以进行功能调节
对来自T细胞的信号作出反应。 这项研究的长期目标是
是理解VLA蛋白质之间惊人的双向联系,
T细胞激活事件,这样我们就可以有一个更好的整体
了解T细胞的发育和功能。 为了实现这一目标,[1]
我将研究T细胞活化(通过抗原、抗体、酯)的结果
在VLA蛋白粘附于细胞和细胞外的快速改变中,
基质配体 特别是,我们将探讨一些VLA函数是如何
可能同时在相反的方向上调节。[2)将
分析VLA蛋白配体或抗VLA单克隆抗体(MAb)
它们本身可以直接或间接地促进T细胞活化,
通过增殖、钙流和淋巴因子分泌来测量。 的
目的#1和#2中提到的研究将利用正常T细胞克隆,
细胞系、T细胞受体(TCR)阴性突变体和TCR重建
突变体,以评估VLA蛋白和TCR之间的连接。[3]在
此外,使用可用的α和β亚基cDNA,我们将删除和
交换VLA蛋白α和β亚基胞质结构域,然后
将测试变体VLA(在T细胞上表达)的i)它们的能力
ii)它们促进T细胞增殖的能力,
activation. 因此,我们将确定胞质结构域在细胞内的作用。
T细胞和VLA蛋白之间的明显双向信号传导。[4]美国
为了研究胸腺细胞上的VLA蛋白,我们将观察它们的阶段-
特异性表达、配体结合功能以及这些功能的调节
功能协调发展的[5]此外,为了充分研究小鼠T细胞上的VLA蛋白,
胸腺细胞,我们将产生急需的抗小鼠VLA蛋白单抗。
这些实验将共同提供重要的见解,
VLA蛋白的各种细胞和细胞外基质配体可以帮助
来指导T细胞发育和功能的有序程序。
英文摘要
T cells, both during development and after maturation, utilize adhesion
receptors in the VLA protein family to interact with other cells and with
extracellular matrix. From preliminary results it now appears that VLA
proteins are not only receptors for substrates or target structures
involved in cell positioning and migration, but also can directly
contribute to signalling through T cells, and can be functionally modulated
in response to signals from T cells. The long term goal of this research
is to comprehend this striking two-way connection between VLA proteins and
T cell activation events, so that we can have a better overall
understanding of T cell development and function. To this goal, [1] we
will look at how T cell activation (by antigen, antibodies, esters) results
in rapid alterations in VLA protein adhesion to both cell and extracellular
matrix ligands. In particular, we will explore how some VLA functions are
possibly regulated in opposite directions at the same time. [2) will
analyze how VLA protein ligands or anti-VLA monoclonal antibodies (MAb)
themselves can directly or indirectly facilitate T cell activation, as
measured by proliferation, calcium flux, and lymphokine secretion. The
studies mentioned in Aims #1 and #2 will utilize normal T cell clones and
lines, T cell receptor (TCR) negative mutants, and TCR reconstituted
mutants to assess the connection between VLA proteins and the TCR. [3] In
addition, using available alpha and beta subunit cDNA's, we will delete and
exchange VLA protein alpha and beta subunit cytoplasmic domains, and then
variant VLA's (expressed on T cells) will be tested for i) their ability
to be functionally regulated, and ii) their ability to facilitate T cell
activation. Thus we will determine the role cytoplasmic domains in the
apparent bi-directional signalling between T cells and VLA proteins. [4]
To investigate VLA proteins on thymocytes, we will look at their stage-
specific expression, ligand-binding functions, and the regulation of these
functions.[5] Also, to adequately study VLA proteins on mouse T cells and
thymocytes we will generate urgently needed anti-mouse VLA protein MAb.
Together these experiments will give important insights into how the
various cellular and extracellular matrix ligands of VLA proteins can help
to direct an orderly program of T cell development and function.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Targeting of tumor cell DHHC3 to enhance anti-cancer immunity
-
批准号:10116321
-
项目类别:
-
资助金额:$40.02万
-
财政年份:2020
-
负责人:MARTIN E HEMLER
-
依托单位:
Targeting of tumor cell DHHC3 to enhance anti-cancer immunity
-
批准号:9884868
-
项目类别:
-
资助金额:$40.02万
-
财政年份:2020
-
负责人:MARTIN E HEMLER
-
依托单位:
Targeting of tumor cell DHHC3 to enhance anti-cancer immunity
-
批准号:10357889
-
项目类别:
-
资助金额:$39.22万
-
财政年份:2020
-
负责人:MARTIN E HEMLER
-
依托单位:
Targeting of tumor cell DHHC3 to enhance anti-cancer immunity
-
批准号:10578679
-
项目类别:
-
资助金额:$39.22万
-
财政年份:2020
-
负责人:MARTIN E HEMLER
-
依托单位:
Interactions of CD147 Involved in MMP Induction
-
批准号:7109287
-
项目类别:
-
资助金额:$29.24万
-
财政年份:2004
-
负责人:MARTIN E HEMLER
-
依托单位:
Interactions of CD147 Involved in MMP Induction
-
批准号:6875392
-
项目类别:
-
资助金额:$27.61万
-
财政年份:2004
-
负责人:MARTIN E HEMLER
-
依托单位:
Interactions of CD147 Involved in MMP Induction
-
批准号:7240497
-
项目类别:
-
资助金额:$28.39万
-
财政年份:2004
-
负责人:MARTIN E HEMLER
-
依托单位:
Interactions of CD147 Involved in MMP Induction
-
批准号:6954232
-
项目类别:
-
资助金额:$27.89万
-
财政年份:2004
-
负责人:MARTIN E HEMLER
-
依托单位:
Interactions of CD147 Involved in MMP Induction
-
批准号:7460726
-
项目类别:
-
资助金额:$28.39万
-
财政年份:2004
-
负责人:MARTIN E HEMLER
-
依托单位:
FASEB Summer Conference--Advance in Tetraspanin Research
-
批准号:6459254
-
项目类别:
-
资助金额:$0.7万
-
财政年份:2002
-
负责人:MARTIN E HEMLER
-
依托单位:
GORDON CONFERENCE ON FIBRONECTIN, INTEGRINS
-
批准号:2010806
-
项目类别:
-
资助金额:$0.7万
-
财政年份:1997
-
负责人:MARTIN E HEMLER
-
依托单位:
GORDON CONFERENCE ON CELL CONTACT AND ADHESION
-
批准号:2112264
-
项目类别:
-
资助金额:$0.6万
-
财政年份:1995
-
负责人:MARTIN E HEMLER
-
依托单位:
FUNCTION AND REGULATION OF VLA MOLECULES ON T CELLS
-
批准号:2184030
-
项目类别:
-
资助金额:$13.83万
-
财政年份:1991
-
负责人:MARTIN E HEMLER
-
依托单位:
SPECIFIC INTEGRIN ALPHA 4 CYTOPLASMIC TAIL FUNCTIONS
-
批准号:2900759
-
项目类别:
-
资助金额:$28.38万
-
财政年份:1991
-
负责人:MARTIN E HEMLER
-
依托单位:
NOVEL INTEGRIN-CD151-PKC SIGNALING COMPLEX
-
批准号:6633747
-
项目类别:
-
资助金额:$33.17万
-
财政年份:1991
-
负责人:MARTIN E HEMLER
-
依托单位:
FUNCTION AND REGULATION OF VLA MOLECULES ON T CELLS
-
批准号:3305973
-
项目类别:
-
资助金额:$11.62万
-
财政年份:1991
-
负责人:MARTIN E HEMLER
-
依托单位:
SPECIFIC INTEGRIN ALPHA 4 CYTOPLASMIC TAIL FUNCTIONS
-
批准号:2392154
-
项目类别:
-
资助金额:$20.96万
-
财政年份:1991
-
负责人:MARTIN E HEMLER
-
依托单位:
SPECIFIC INTEGRIN ALPHA 4 CYTOPLASMIC TAIL FUNCTIONS
-
批准号:2184032
-
项目类别:
-
资助金额:$18.88万
-
财政年份:1991
-
负责人:MARTIN E HEMLER
-
依托单位:
SPECIFIC INTEGRIN ALPHA 4 CYTOPLASMIC TAIL FUNCTIONS
-
批准号:2684973
-
项目类别:
-
资助金额:$21.78万
-
财政年份:1991
-
负责人:MARTIN E HEMLER
-
依托单位:
NOVEL INTEGRIN-CD151-PKC SIGNALING COMPLEX
-
批准号:6133887
-
项目类别:
-
资助金额:$29.2万
-
财政年份:1991
-
负责人:MARTIN E HEMLER
-
依托单位:
海外基金